Janus Henderson Group’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,230
Closed -$199K 2414
2025
Q2
$199K Sell
15,230
-73,364
-83% -$1.01M ﹤0.01% 2320
2025
Q1
$1.33M Sell
88,594
-44,708
-34% -$768K ﹤0.01% 1484
2024
Q4
$2.42M Buy
133,302
+26,432
+25% +$356K ﹤0.01% 1216
2024
Q3
$1.44M Sell
106,870
-7,480
-7% -$110K ﹤0.01% 1473
2024
Q2
$1.58M Sell
114,350
-4,074
-3% -$64.5K ﹤0.01% 1366
2024
Q1
$2.22M Sell
118,424
-5,659
-5% -$113K ﹤0.01% 1247
2023
Q4
$2.81M Sell
124,083
-13,802
-10% -$299K ﹤0.01% 1065
2023
Q3
$3.42M Buy
137,885
+33,312
+32% +$838K ﹤0.01% 934
2023
Q2
$2.94M Buy
104,573
+22,106
+27% +$549K ﹤0.01% 1049
2023
Q1
$1.84M Buy
82,467
+32,644
+66% +$855K ﹤0.01% 1313
2022
Q4
$1.32M Sell
49,823
-59,495
-54% -$1.94M ﹤0.01% 1229
2022
Q3
$3.1M Buy
109,318
+54,372
+99% +$1.4M ﹤0.01% 1136
2022
Q2
$1.15M Buy
54,946
+27,116
+97% +$508K ﹤0.01% 1264
2022
Q1
$603K Buy
+27,830
New +$604K ﹤0.01% 1776

Other funds holding CCRN

Janus Henderson Group's CCRN Position: Q3 2025 in Review

Janus Henderson Group sold out of Cross Country Healthcare (CCRN) in Q3 2025, closing a stake of 15,230 shares — an estimated $199K sold.

Janus Henderson Group first reported a position in CCRN in Q1 2022 and held it in 14 quarters. The position peaked at $3.42M in Q3 2023. 169 funds tracked by Wall St. Rank hold CCRN as of Q3 2025.

  • Janus Henderson Group reported no remaining Cross Country Healthcare position as of Q3 2025 after selling out during the quarter.
  • Janus Henderson Group sold 15,230 Cross Country Healthcare shares in Q3 2025, an estimated $199K.
  • Janus Henderson Group first reported a position in Cross Country Healthcare in Q1 2022 and held it in 14 quarters.
  • Janus Henderson Group's Cross Country Healthcare position peaked at $3.42M in Q3 2023.
  • 169 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2025.

Based on Janus Henderson Group's 13F filing for Q3 2025, filed 14 Nov 2025.